Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(2024)
Key words
non-small-cell lung cancer,epidermal growth factor receptor,compound mutation,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined